{"id":"W2035237515","doi":"10.1016/s0049-3848(10)70009-8","title":"Potential of new anticoagulants in patients with cancer","year":2010,"lang":"en","type":"review","venue":"Thrombosis Research","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Thrombosis; Heparin; Intensive care medicine; Cancer; Anticoagulant; Surgery; Internal medicine; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007305699,0.0003735948,0.003153408,0.001021411,0.00006875901,0.00003470847,0.000440042,0.0004037588,0.001105707],"category_scores_gemma":[0.00008833712,0.0002555747,0.0002585358,0.001144493,0.0002390415,0.00007191576,0.0003158108,0.001405395,0.00009884781],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002221967,"about_ca_system_score_gemma":0.001248946,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002764632,"about_ca_topic_score_gemma":0.0003088288,"domain_scores_codex":[0.9961154,0.0002066069,0.0006824228,0.0006084806,0.001613921,0.0007731095],"domain_scores_gemma":[0.99818,0.0001004611,0.000223324,0.0008541826,0.0003624515,0.0002795436],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004982319,0.001899911,0.005999857,0.01623062,0.000579044,0.00001888062,0.0001046222,7.86461e-7,0.000004511108,0.0000684213,0.00727596,0.9677675],"study_design_scores_gemma":[0.00211312,0.0008654423,0.2441454,0.03179538,0.001355227,0.000001651078,0.00002460589,0.00000197063,0.00001030554,0.00002064427,0.7193115,0.0003546939],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0192017,0.9743398,0.000002737023,0.0001347843,0.0002627523,0.003872003,0.00006487504,0.00002597025,0.002095348],"genre_scores_gemma":[0.002792318,0.9959847,0.0001645009,0.00002016708,0.0002299715,0.0001702385,0.000127348,0.0001028056,0.0004079364],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9674129,"threshold_uncertainty_score":0.9999896,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1341334075173738,"score_gpt":0.4567190331860814,"score_spread":0.3225856256687076,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}